Novel CD19/BCMA Dual-Targeted CAR-T Cell Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07359014 · RECRUITING
Trial details
- NCT number
- NCT07359014
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2027-10-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.